CAS 446262-90-4
:CJC 1295
Description:
CJC-1295 is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is primarily used in research settings to study its effects on growth hormone secretion and potential therapeutic applications. CJC-1295 is characterized by its ability to stimulate the pituitary gland to release growth hormone, which can lead to increased muscle mass, fat loss, and improved recovery. The peptide has a long half-life due to its modification, which allows for sustained release and prolonged activity in the body. It is typically administered via subcutaneous injection. CJC-1295 is often studied in the context of anti-aging, bodybuilding, and metabolic disorders, although its use in humans is not approved by regulatory agencies. As with any peptide, the safety profile and potential side effects are important considerations, and ongoing research continues to explore its efficacy and mechanisms of action.
Formula:Unspecified
Synonyms:- CJC 1295
- L-Lysinamide, L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-
- L-Tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-L-lysinamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
CJC-1295 trifluoroacetate
CAS:<p>A synthetic peptide that stimulates growth hormone release through GHRH receptors. TFA salt</p>Formula:C165H269N47O46Purity:Min. 95%Color and Shape:PowderMolecular weight:3,647.19 g/mol
